Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

NYSE: Short Term Outlook Remains 'Neutral'

Published 04/27/2016, 09:05 AM
Updated 07/09/2023, 06:31 AM

Psychology Remains Somewhat Cautionary

Opinion: The majority of the indexes closed higher yesterday with the exception of the COMPQX closing lower. Internals were positive as volumes rose from the prior session. There were some positive and negative technical events on the charts that remain largely in their short term sideways ranges. Little change was seen in the data that now finds the psychology segment turning slightly cautionary. Thus, based on the charts and data, we remain near term “neutral” in our outlook while high valuation keeps us “neutral” for the intermediate term as well.

  • On the charts, all of the indexes closed higher with the exception of the COMPQX (page 3) that closed lower and below its intermediate term uptrend line from the beginning of March. However, its support was not violated. The only other technical event of note was the RUT (page 4) that closed above short term resistance. The rest of the index charts remain confined within their current short term sideways patterns.

  • Little changed regarding the data. All of the 1 day McClellan OB/OS Oscillators remain neutral (All Exchange:+2.95 NYSE:-1.69 NASDAQ:+7.98) with the NASDAQ 21 day slipping back to a neutral +46.68. The All Exchange and NYSE 21 day levels remain overbought at +64.96 and +82.28 respectively. Psychology data remains somewhat of a concern as the Gambill Insider Buy/Sell Ratio remains a bearish 6.2 as insiders continue selling and the pros measured by the OEX Put/Call Ratio (smart money) are weighted in puts at a bearish 1.68. The Rydex Ratio (contrary indicator) still shows the leveraged ETF traders heavily leveraged long at 59.1. As such, while the OB/OS short term data is neutral, some clouds are gathering in the psychology area.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

  • In conclusion, the charts remain in their sideways patterns with data not quite tilted enough to the cautionary side to alter our near term “neutral” outlook for the indexes.

  • For the intermediate term, we remain “neutral” as the forward 12 month p/e based on IBES forward 12 month earnings estimates has lifted to a 16.9 multiple and just shy of the level seen prior to the January correction.

  • Forward 12 month earnings estimates for the SPX from IBES of $123.58 leave a 5.92% forward earnings yield on a 16.9 forward multiple.

SPX: 2,074/2,106

DJI: 17,541/8,114

COMPQX; 4,836/5,001

DJT: 7,921/8,239

MID: 1,451/1,491

RUT: 1,107/1,162

VALUA: 4,525/4,685

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.